Evidence map›Paper›PMID 42765945›Full record

ArticleDiabetes care2026

Association of Age at Type 1 Diabetes Onset With Survival, Cardiovascular, and Kidney Outcomes: A Nationwide Cohort Study.

Araz Rawshani, Björn Eliasson, Darren K McGuire, Naveed Sattar, Hertzel C Gerstein, Jetish Isufi, Julia Zaccai, Aymeric Mahieu, Aidin Rawshani

Abstract read
PubMed Publisher
In one paragraph

Article in Diabetes care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Araz RawshaniDepartment of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.ORCID 0000-0003-2066-3533
Björn EliassonDepartment of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
Darren K McGuireDivision of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX.
Naveed SattarSchool of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, U.K.
Hertzel C GersteinPopulation Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.
Jetish IsufiDepartment of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.
Julia ZaccaiSanofi, Paris, France.
Aymeric MahieuSanofi, Paris, France.
Aidin RawshaniDepartment of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.ORCID 0000-0002-4509-873X

Funding

Sanofi
6 · The paper itself

Abstract

objectiveTo investigate the association of age at type 1 diabetes diagnosis with incident mortality, cardiovascular, and kidney outcomes. RESEARCH DESIGN AND

methodsIn this retrospective cohort study, individuals ≥18 years of age with type 1 diabetes with one or more entries in the Swedish National Diabetes Register (from January 1998 to December 2019) were followed from the date of first registration up to December 2020. Cox proportional hazards models were used to examine risk per 1-year increase in age at type 1 diabetes diagnosis and excess risk relative to comparator individuals from the Swedish Total Population Register.

resultsCohorts consisted of 34,155 individuals with type 1 diabetes and 150,026 comparator individuals. The hazard ratio (HR) per 1-year increase in age at type 1 diabetes diagnosis was 0.98 (95% CI 0.98, 0.99) for all-cause mortality, indicating a 1.7% lower probability per 1-year increase in age at type 1 diabetes diagnosis (8.2% lower probability per 5-year increase). Corresponding HRs per 1-year increase in age at diagnosis were 0.97 (0.97, 0.98) for cardiovascular mortality and 0.99 (0.98, 0.99) for noncardiovascular mortality. Excess risk relative to comparator individuals was greatest when type 1 diabetes diagnosis occurred from 0 to 10 years of age, with HRs of 3.23 (2.92, 3.58) for all-cause mortality, 5.73 (4.32, 7.59) for cardiovascular mortality, and 3.01 (2.70, 3.36) for noncardiovascular mortality.

conclusionsYounger age at type 1 diabetes diagnosis is associated with greater risk of mortality and complications, with each additional year delay in onset being significantly associated with lower risk.

Indexed as

Cardiovascular DiseasesDiabetes Mellitus, Type 1AdolescentAdultAge of OnsetFemaleHumansMaleMiddle AgedProportional Hazards ModelsRetrospective StudiesSwedenYoung Adult

Identifiers

PMID42765945

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.